Asia Spotlight: Hot Money Fuels China Biotech ‘Me-Different’ Ambitions
Adagene is the latest antibody firm to receive millions in financing, adding to a growing list of upcoming Chinese biotechs looking to differentiate in a largely unpenetrated yet competitive biologics market.
You may also be interested in...
The first vaccine for the new coronavirus has entered the clinic, with US firm Moderna leading the race.
Podcast: Living In China's Coronavirus Lockdown; Novartis and England's 'Public Health' Alliance; Biogen's Moment of Truth Approaches
Several newly repurposed drugs, including a Bayer antimalarial, have shown potential benefits against the new coronavirus, promoting China to add several to its latest revised treatment guidelines.